SCHEMBL18878239

SCHEMBL18878239

O=C1N(Cl)C(=O)N(Cl)C(O)N1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31006320 0.69
SCHEMBL14596382 0.69
SCHEMBL31563006 0.58 ENO1 (0.31)
SCHEMBL472598 0.55
SCHEMBL16241627 0.54 ADRA2C (0.30)
SCHEMBL16253382 0.54 ADRA2C (0.30)
SCHEMBL237156 0.54
SCHEMBL10746690 0.50 ADRA2C (0.56)
SCHEMBL223179 0.50 ADRA2C (0.56)
Symclosene SCHEMBL28549965 0.49

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210363142-A1 AGONISTS OF THE APELIN RECEPTOR AND METHODS OF USE THEREOF Sanford Burnham Prebys Medical Discovery Institute 2021-11-25 US disclosed
US-10370379-B2 Compounds and compositions useful for treating disorders related to NTRK BLUEPRINT MEDICINES CORPORATION (US) 2019-08-06 US disclosed
US-10280163-B2 5 or 8-substituted imidazo[1, 5-a] pyridines as indoleamine and/or tryptophane 2, 3-dioxygenases BEIGENE, LTD. (KY) 2019-05-07 US disclosed
US-20180118665-A1 FTO Inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2018-05-03 US disclosed
US-20180072716-A1 NOVEL 5 OR 8-SUBSTITUTED IMIDAZO[1, 5-a] PYRIDINES AS INDOLEAMINE AND/OR TRYPTOPHANE 2, 3-DIOXYGENASES BEONE MEDICINES I GMBH (CH) 2018-03-15 US disclosed
US-20170145018-A1 COMPOUNDS AND COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO NTRK BLUEPRINT MEDICINES CORPORATION 2017-05-25 US disclosed